Risk Factors and Outcome of Seizures After Spontaneous Aneurysmal Subarachnoid Hemorrhage
Overview
Affiliations
Background And Purpose: Seizures are important neurologic complications of spontaneous aneurysmal subarachnoid hemorrhage (SAH). A better understanding of the risk factors of seizures following aneurysmal SAH is needed to predict those who will require treatment.
Methods: A total of 137 adult patients were enrolled in this two-year retrospective study. Baseline prognostic variables were analyzed based on Cox's proportional hazards model after a minimum of one-year follow-up.
Results: Seizures occurred in 21 patients who had SAH, including acute symptomatic seizures in 11.7% (16/137) and unprovoked seizures in 3.6% (5/137). None progressed to status epilepticus during hospitalization. After a minimum of one-year follow-up, the mean Glasgow Outcome Score was 3.5 +/- 1.4 for patients with seizures and 3.1 +/- 1.1 for those without.
Conclusions: Higher mean World Federation of Neurological Societies grade on presentation was predictive of seizure, but seizure itself was not a significant prognostic predictor after a minimum of one-year follow-up. Regarding potential side effects of anti-epileptic drugs, anti-epileptic therapy should be carefully administered to patients with seizures after aneurysmal SAH.
Effects of Hemosiderosis on Epilepsy Following Subarachnoid Hemorrhage.
Hirano T, Enatsu R, Iihoshi S, Mikami T, Honma T, Ohnishi H Neurol Med Chir (Tokyo). 2018; 59(1):27-32.
PMID: 30568071 PMC: 6350000. DOI: 10.2176/nmc.oa.2018-0125.
Kodankandath T, Farooq S, Wazni W, Cox J, Southwood C, Rozansky G J Vasc Interv Neurol. 2018; 9(6):1-4.
PMID: 29445430 PMC: 5805895.
Panczykowski D, Pease M, Zhao Y, Weiner G, Ares W, Crago E Stroke. 2016; 47(7):1754-60.
PMID: 27301932 PMC: 4927347. DOI: 10.1161/STROKEAHA.116.013766.
Yoon S, Joo J, Kim Y, Hong C, Chung J J Cerebrovasc Endovasc Neurosurg. 2015; 17(3):166-72.
PMID: 26526008 PMC: 4626338. DOI: 10.7461/jcen.2015.17.3.166.
Marigold R, Gunther A, Tiwari D, Kwan J Cochrane Database Syst Rev. 2013; (6):CD008710.
PMID: 23740537 PMC: 6885058. DOI: 10.1002/14651858.CD008710.pub2.